Partial spleen removal may boost immunity in liver cirrhosis patients
NCT ID NCT07205471
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at whether removing only part of the spleen (instead of the whole spleen) can improve immune function in people with liver cirrhosis who have an overactive spleen (hypersplenism). About 30 adults will be enrolled. Researchers will measure immune markers and blood counts before and after surgery to see if this approach leads to better outcomes.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CIRRHOSES, LIVER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Clinical Medical College of Yangzhou University
RECRUITINGYangzhou, Jiangsu, 225001, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can tracking hospital care for liver patients reduce repeat admissions?
- 300 cirrhosis patients join study to uncover hidden triggers of liver cancer
- Spleen surgery may reshape fat levels in liver patients
- Can spleen surgery shield kidneys in cirrhosis? new study aims to find out
- Can spleen surgery save kidneys in liver patients?
- Spleen surgery may change fat levels in liver patients – study to watch